United states trends in the surgical treatment of primary breast cancer

World Journal of Surgery

Volumn 36, Issue 7, 2012, Pages 1475-1479

  Tuttle, Todd M ^a   Rueth, Natasha M ^a   Abbott, Andrea ^a   Virnig, Beth A ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; BREAST TUMOR; FEMALE; HUMAN; MASTECTOMY; REVIEW; RISK FACTOR; SEGMENTAL MASTECTOMY; STATISTICS; TUMOR RECURRENCE; UNITED STATES;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RISK FACTORS; UNITED STATES;

EID: 84864287447     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1469-4     Document Type: Article

References (48)

1. Fisher B, Bauer M, Margolese R et al (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673 (Pubitemid 15134702)
2. Lazovich D, Solomon CC, Thomas DB et al (2000) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628-637 (Pubitemid 29379408)
3. National Institutes of Health consensus conference (1991) Treatment of early-stage breast cancer. JAMA 265:391-395
4. McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5,685 patients. Ann Surg Oncol 16:2682-2690
5. Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082-4088
6. Morrow M (2009) More mastectomies: is this what patients really want? J Clin Oncol 27:4038-4040
7. Balch CM, Jacobs LK (2009) Mastectomies on the rise for breast cancer: the tide is changing. Ann Surg Oncol 16:2669-2672
8. Habermann EB, Abbott A, Parsons HM et al (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28:3437-3441
9. Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102-1107
10. Al-Refaie W, Kuerer HM, Khuwaja A et al (2005) Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190:602-605 (Pubitemid 41306086)
11. Hershman DL, Buono D, Jacobson J et al (2009) Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg 249:828-833
12. Gilligan MA, Kneusel RT, Hoffmann RG et al (2002) Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40:181-189
13. Hawley ST, Griggs JJ, Hamilton AS et al (2009) Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst 101: 1337-1347
14. Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209 (Pubitemid 350232251)
15. Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362-1367
16. McLaughlin CC, Lillquist PP, Edge SB (2005) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404-5412
17. Sobero ME, Dick AW, Beckjord EB et al (2009) Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597-1605
18. Jones NB, Wilson J, Kotur L et al (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691-2696
19. Metcalfe KA, Lubinski J, Ghadirian P et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26:1093-1097
20. Arrington AK, Jarosek SL, Virnig BA et al (2009) Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697-2704
21. Abbott A, Rueth N, Pappas-Varco S et al (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129-3136
22. Black WC, Nease RF Jr, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87:720-731
23. Alexander NE, Ross J, Sumner W et al (1996) The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11:92-97 (Pubitemid 26088067)
24. Partridge A, Adloff K, Blood E et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100:243-251 (Pubitemid 351480537)
25. Rakovitch E, Franssen E, Kim J et al (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77:285-293 (Pubitemid 36197643)
26. Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319-324 (Pubitemid 30469858)
27. Montgomery LL, Tran KN, Heelen MC et al (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6:546-552 (Pubitemid 29428793)
28. Geiger AM, Nekhlyudov L, Herrinton LJ et al (2007) Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14:686-694 (Pubitemid 46175315)
29. Altschuler A, Nekhlyudov L, Rolnick SJ et al (2008) Positive, negative, and disparate: women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14:25-32
30. Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275-4286 (Pubitemid 46207002)
31. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241 (Pubitemid 35176242)
32. Veronesi U, Saccozzi R, Del Vecchio M et al (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6-11 (Pubitemid 11071189)
33. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087- 2106
34. Freedman RA, He Y, Winer EP et al (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27:713-719
35. Malin JL, Kahn KL, Adams J et al (2002) Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835-844 (Pubitemid 34705055)
36. Daroui P, Gabel M, Khan AJ et al (2011) Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis. Am J Clin Oncol. doi:10.1097/ COC.0b013e318209aa57
37. Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977 (Pubitemid 39166260)
38. Tuttle TM, Jarosek S, Habermann EB et al. (2011) Omission of radiation therapy after breast-conserving surgery in the United States: a population-based analysis of clinicopathologic factors. Cancer. doi:10.1002/cncr.26505
39. Nattinger AB, Kneusel RT, Hoffmann RG et al (2001) Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93:1344-1346 (Pubitemid 32910576)
40. Abbott AM, Habermann EB, Tuttle TM (2011) Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer 117:3305- 3310
41. Hologic. MammoSite. Available at: http://www.mammosite.com. Accessed Jul 6 2010
42. Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045 (Pubitemid 36794035)
43. Nichols HB, de González AB, Lacey JV Jr et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564-1569
44. Lostumbo L, Carbine N, Wallace J et al (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (4):CD002748
45. Peele PB, Siminoff LA, Xu Y et al (2005) Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making 25:301-307 (Pubitemid 40696279)
46. Sanghani M, Truong PT, Raad RA et al (2010) Validation of a webbased predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 28:718-722
47. Bickell NA, Shastri K, Fei K et al (2008) A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst 100:1717-1723
48. Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513-520